You're not logged in. Please log in to earn stock or Bitcoin rewards on your prescription purchase.
Fiasp FlexTouch
Fiasp FlexTouch is a rapid-acting insulin used to control blood sugar levels in individuals with diabetes mellitus, including type 1 and type 2 diabetes. It is typically administered at mealtimes to help manage postprandial blood sugar spikes. Fiasp works faster than regular insulin due to the addition of niacinamide (vitamin B3), which speeds up absorption. The FlexTouch pen is a pre-filled, disposable insulin pen that allows for easy and accurate insulin administration.
Rx. Enter your prescription
How would you like to get your prescription? Select an option
Pharmacy pickup
Select from 35,000 pharmacies
Free two-day delivery
Coming soon!
Find a pharmacy near you. Enter your ZIP code
Are you a member? Sign up or log in.
Members have saved
$NaN
using our savings card for instant savings.
Don't pay full retail price and miss out on potential savings. Try it now—you have nothing to lose!
NaNM
worth of Satoshi has been rewarded to our members.
Everyone who signs up enjoys the benefits of earning FREE Bitcoin with every purchase.
How much Bitcoin can you earn with Fiasp FlexTouch ?
The potential for Bitcoin rewards to increase and appreciate in value is a possibility to consider, which may occur over time.
See the value of your savings today
Today's Value
1 Bitcoin = $NaN
Bitcoin (BTC)
...
USD
$NaN
Adjust Bitcoin's potential value to see how much it could be worth
Potential Value
1 Bitcoin =
Bitcoin (BTC)
...
USD
$NaN
Frequently Asked Questions
How quickly does Fiasp FlexTouch start working?
Fiasp starts working within 2 to 5 minutes after injection, making it one of the fastest-acting insulins available.
Can Fiasp FlexTouch be used for Type 1 diabetes?
Yes, Fiasp is used for managing Type 1 diabetes in both adults and children, typically administered before meals to control blood sugar spikes.
What should I do if I miss a dose of Fiasp FlexTouch?
If you miss a dose, take it as soon as possible, either right before eating or within 20 minutes after starting a meal. If it’s been longer than that, skip the missed dose and continue with your regular dosing schedule.
Can I combine Fiasp with other insulins?
Yes, Fiasp can be used alongside long-acting insulin to manage blood sugar throughout the day and night. However, it should not be mixed with other insulins in the same syringe.
How should I store Fiasp FlexTouch?
Store unused Fiasp pens in the refrigerator. Once in use, the pen can be stored at room temperature for up to 28 days.
Comprehensive Drug Guide
How Does Fiasp FlexTouch Work?
Fiasp (insulin aspart) works by mimicking the body’s natural insulin. After injection, it helps lower blood sugar by facilitating the movement of glucose from the bloodstream into cells for energy. Fiasp begins to work within 2 to 5 minutes after injection, making it faster than other rapid-acting insulins. It helps manage blood sugar levels after meals and is usually taken alongside long-acting insulin to provide basal insulin coverage.
Common Dosages
For Type 1 and Type 2 diabetes: Fiasp FlexTouch is usually taken immediately before meals or up to 20 minutes after starting a meal. Dosage adjustments are made based on blood sugar readings, carbohydrate intake, and your doctor’s recommendations.
Typical Dosing
FDA Approved Indications
- Type 1 diabetes in adults and children to improve blood sugar control.
- Type 2 diabetes in adults to improve blood sugar control.
Who Shouldn't Take Fiasp FlexTouch?
- Hypoglycemia (low blood sugar).
- Allergy or hypersensitivity to insulin aspart or any components of the formulation.
Advice From The Pharmacist
- Use Fiasp FlexTouch before meals or within 20 minutes of starting a meal. Ensure that you adjust your dosage based on your blood sugar levels and carbohydrate intake.
- Rotate injection sites to prevent skin changes (lipodystrophy). Common injection sites include the abdomen, thigh, and upper arm.
- Monitor blood sugar levels regularly, especially when starting or adjusting your insulin dose.
- Store unused pens in the refrigerator. Once in use, the pen can be kept at room temperature for up to 28 days.
Side Effects of Fiasp FlexTouch
Common Side Effects
- Hypoglycemia (low blood sugar)
- Injection site reactions (redness, swelling, or pain)
- Weight gain
- Skin changes at the injection site (lipodystrophy)
Uncommon/Severe Side Effects
- Severe hypoglycemia, which can lead to unconsciousness, seizures, or death if untreated.
- Allergic reactions, such as swelling, rash, or difficulty breathing.
- Hypokalemia (low potassium levels), which can cause heart irregularities.
Risks and Warnings of Fiasp FlexTouch
- Hypoglycemia Risk: Fiasp may cause severe hypoglycemia, especially if administered without adequate food intake. It is important to have a fast-acting source of glucose (such as glucose tablets or juice) readily available in case of low blood sugar.
- Hypokalemia: Insulin therapy can cause low potassium levels. Individuals with pre-existing low potassium or those using potassium-lowering medications should be monitored.
- Weight Gain: Insulin therapy may contribute to weight gain, particularly when tight blood sugar control is achieved.
Interactions with Fiasp FlexTouch
Common Drug Interactions
- Oral diabetes medications: Fiasp may be used in combination with oral medications like metformin, but dosage adjustments may be necessary.
- Beta-blockers: These medications can mask the symptoms of hypoglycemia, such as increased heart rate and tremors.
- Alcohol: Alcohol can increase the risk of hypoglycemia when combined with insulin.
Alternatives to Fiasp FlexTouch
- NovoLog FlexPen (insulin aspart): Another rapid-acting insulin similar to Fiasp, used for mealtime blood sugar control.
- Humalog KwikPen (insulin lispro): Another rapid-acting insulin analog used for controlling post-meal blood sugar levels.
- Apidra SoloStar (insulin glulisine): A rapid-acting insulin used for controlling blood sugar around meals.
- Basaglar (insulin glargine): A long-acting insulin that may be used alongside Fiasp for basal insulin coverage.
